- Country: Serbia
- Summary: Medicines for Human Use - the Institution Procures (Documents from the D-Do not Purchased through the Cjn, Drugs that are not on the List of Medicines)
- RST Ref No: 113714024
- Deadline: 14 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RSD 16469112.00
- Notice Type: Tender
- Document Ref. No.: JN-5/25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Ticagrelor, tablet film, 90 mg, ceftazidim, avibibatt; powder for an infusion solution concentrate; 2g + 0.5g, levosimendan; concentrate for an infusion solution; 2.5mg/ml, inclusive, solution for injection in a filled injection syringe, 284mg, Phenilephrin injection, 10mg/ml, acetylcystein; solution
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines for Human Use - the Institution Procures (Documents from the D-Do not Purchased through the Cjn, Drugs that are not on the List of Medicines) - Serbia Tender
The INSTITUTE FOR CARDIOVASCULAR DISEASES OF VOJVODINA, a Government sector organization in Serbia, has announced a new tender for Medicines for Human Use - the Institution Procures (Documents from the D-Do not Purchased through the Cjn, Drugs that are not on the List of Medicines). This tender is published on SerbiaTenders under RST Ref No: 113714024 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-14.
The estimated tender value is RSD 16469112.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
